Diligence memo · auto-generated · as of July 2, 2026

Bovie Medical Corp

Bovie Medical Corp looks fair against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Bovie Medical Corp operates in Other Health Care, based in Clearwater.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Bovie Medical Corp has raised $10M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).

Largest single filing: $7.0M on 2013-12-13.

Most recent recorded round closed around 2013-12-13.

Valuation (modeled)modeled

Provath models Bovie Medical Corp at approximately $141M (range $9.0M–$768M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 1.17× the median modeled value of Series A Other Health Care companies in 2013–2015 (187 peers) — value vs value, same stage and era. Within the normal band (117% of peer median) for its niche.

Financing rhythm & timingmixed

Historic cadence: a new round about every 44 months.

Last raise 12.5 yr ago; this sector typically re-raises about every 14 months.

Silent for over 3× the sector's normal cadence.

The last round stepped up 2.3× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 76% of Other Health Care peers (5377 compared).

Modeled value ranks above 84% of those peers.

Closest niche peers: Imagine Health, Inc., Spruce Health, Inc., Inova Labs, Inc., Cephea Valve Technologies, Inc., ClarVista Medical, Inc..

Peoplefiled

16 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.